This is a preview of subscription content, log in via an institution to check access.
REFERENCE
Brennan A, Akehurst R, Davis S, Sakai H, Abbott V.The cost-effectiveness of lanthanum carbonate in the treatment of hyperphosphatemia in patients with end-stage renal disease. Value in Health 10: 32-41, No. 1, Jan-Feb 2007
Rights and permissions
About this article
Cite this article
Lanthanum carbonate cost effective for hyperphosphataemia. Pharmacoecon. Outcomes News 526, 6 (2007). https://doi.org/10.2165/00151234-200705260-00013
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200705260-00013